• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS PSA REAGENT PACK; IN VITRO DIAGNOSTICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS PSA REAGENT PACK; IN VITRO DIAGNOSTICS Back to Search Results
Catalog Number 6801756
Device Problem Low Test Results (2458)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 06/04/2020
Event Type  malfunction  
Manufacturer Narrative
The investigation has determined that lower than expected vitros tsh and psa results were obtained from multiple patient samples and quality control fluids tested on a vitros eciq immunodiagnostic system.An ortho laboratory specialist (ls) performed precision and accuracy studies by processing patient samples and quality control fluids without calibrating the assays post service actions.The ortho ls did not realize the qc results were out of range prior to running the patient samples.Once the ls noticed the qc results were unacceptable, she recalibrated the assays to resolve the issue.The assignable cause of the results obtained post service/before recalibration were concluded to be user error with not calibrating following significant service actions performed by an ortho field engineer.In the vitros eci/eciq operators guide it specifically states that you may need to perform calibration after service procedures are performed.The assignable cause of the data points obtained post service/post recalibration (tsh 3.31, 5.72 miu/l; psa 1.57, 9.36, 14.4 ng/ml) was unknown as the customer accepted the results and no further investigation was performed.
 
Event Description
An ortho clinical diagnostics (ortho) laboratory specialist (ls) contacted the technical solutions center (tsc) to report a lower than expected tsh and psa results obtained from quality control (qc) fluids and patient samples processed using vitros tsh and psa reagent on a vitros eciq immunodiagnostics system.Vitros psa lot 3840: sample (b)(6) = 1.12, 1.57 versus expected 2.17 ng/ml.Sample (b)(6) = 2.0 versus expected 3.23 ng/ml.Sample (b)(6) = 6.41, 9.36 versus expected 12.94 ng/ml.Sample (b)(6) = 0.992 versus expected 1.54 ng/ml.Sample (b)(6) = 9.88, 14.4 versus expected 32.62 ng/ml.Sample (b)(6) = 2.48 versus expected 3.52 ng/ml.Biorad level 3 = 8.79 versus expected 13.9 ng/ml.Vitros tsh lot 6170: sample (b)(6) = 3.4 versus expected 5.04 miu/l.Sample (b)(6) = 0.503 versus expected 0.997 miu/l.Sample (b)(6) = 3.11 versus expected 4.5 miu/l.Sample (b)(6) = 2.37 versus expected 3.6 miu/l.Sample (b)(6) = 0.814 versus expected 1.28 miu/l.Sample (b)(6) = 50.7 versus expected >100 miu/l.Sample (b)(6) = 9.95 versus expected 17.67 miu/l.Biorad level 1 = 0.198 versus expected 0.307 miu/l.Biorad level 3 = 19.3 versus expected 29.3 miu/l.Sample (b)(6) = 3.31 versus expected 2.42 miu/l.Sample (b)(6) = 5.72 versus expected 3.94 miu/l.Biased results of the magnitude and direction observed may lead to inappropriate physician action if they were to occur undetected on patient samples.The lower than expected vitros tsh and psa results obtained were part of a method comparison study and were not reported from the laboratory.There were no allegations of patient harm as a result of this event.This report is number 2 of 2 mdr¿s for this event.Two (2) 3500a forms are being submitted for this event as 2 devices were involved.This report corresponds to ortho clinical diagnostics inc.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITROS IMMUNODIAGNOSTIC PRODUCTS PSA REAGENT PACK
Type of Device
IN VITRO DIAGNOSTICS
Manufacturer (Section D)
ORTHO-CLINICAL DIAGNOSTICS
100 indigo creek drive
rochester NY 14626
Manufacturer (Section G)
ORTHO CLINICAL DIAGNOSTICS
felindre meadows
pencoed
bridgend, wales CF35 5PZ
UK   CF35 5PZ
Manufacturer Contact
james a stevens
100 indigo creek drive
rochester, NY 14626
5854533000
MDR Report Key10220932
MDR Text Key230615574
Report Number3007111389-2020-00068
Device Sequence Number1
Product Code LTJ
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Other
Type of Report Initial
Report Date 07/01/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/24/2020
Device Catalogue Number6801756
Device Lot Number3840
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 06/05/2020
Initial Date FDA Received07/01/2020
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/30/2020
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-